Literature DB >> 19530050

Cavernous hemangioma: unusual benign tumor of the transverse colon.

Ramon Vilallonga1, Eloy Espin Basany, Manuel Armengol.   

Abstract

Cavernous hemangioma of the colon is an uncommon disease and a rare cause of bleeding. Few cases have been reported in the literature. The rectosigmoid is the most common site of this disease in the gastrointestinal tract, while colonic localization is very uncommon. We report the case of a 66-year-old female with recurrent episodes of rectal bleeding. She underwent a colonoscopy and was diagnosed with diffuse cavernous hemangioma of the transverse colon. A laparoscopic extended right hemicolectomy was performed. Colonic hemangiomas are very rare vascular malformations and their clinical presentation is usually acute, recurrent or chronic rectal bleeding. This tumor can be diagnosed as solitary, multiple, or part of a more complex syndrome with cutaneous manifestations. They can also invade adjacent structures. Colonoscopy is a useful diagnostic test. The extension of the lesion, its morphology and its localization can be established, but imaging such as magnetic resonance or computerized tomography scan has to be performed. Sometimes, however, recognition of these tumors is difficult and can be a cause of failed surgical treatment and severe complications. Surgical treatment is recommended, after a full diagnostic evaluation for other causes of gastrointestinal bleeding.

Entities:  

Mesh:

Year:  2009        PMID: 19530050

Source DB:  PubMed          Journal:  Turk J Gastroenterol        ISSN: 1300-4948            Impact factor:   1.852


  2 in total

1.  Diffuse hemolymphangioma of the rectum: a report of a rare case.

Authors:  Gang Chen; Wei Cui; Xi-Qing Ji; Jun-Feng Du
Journal:  World J Gastroenterol       Date:  2013-03-07       Impact factor: 5.742

2.  Vascular Malformation of the Colorectum in Children: Case Series of 27 Patients.

Authors:  Chunhui Peng; Sarah Siyin Tan; Wenbo Pang; Zengmeng Wang; Dongyang Wu; Kai Wang; Yajun Chen
Journal:  World J Surg       Date:  2021-06-29       Impact factor: 3.352

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.